ANGELALIGN (06699) has announced a positive profit alert, forecasting a net profit for the 2025 fiscal year in the range of approximately $24 million to $30 million. This represents a significant increase of 140% to 200% compared to the net profit of about $10 million recorded for the fiscal year ended December 31, 2024. The Board of Directors attributes this anticipated profit growth primarily to several key factors: increased adoption of the Group's invisible aligner solutions, driven by excellent clinical outcomes and customer service capabilities in international markets, coupled with continued penetration into lower-tier cities and the early orthodontic treatment segment within China; enhanced operational efficiency and economies of scale resulting from the Group's mature global sales network and world-class service and clinical support infrastructure, with previous investments in localized sales, service, operational capabilities, and back-office functions in key markets now translating into higher operational leverage; lower-than-expected capital expenditure and operating expenses for the 2025 fiscal year due to delayed cost progression for the commissioning of certain production facilities outside China; a limited financial impact in the reporting period due to the timing of recognition for certain legal and professional fees, as some intellectual property-related matters were still in preliminary procedural stages during the 2025 fiscal year; and a relatively low profit base in the 2024 fiscal year, which was affected by significant strategic investments.